肿瘤坏死因子抑制剂已经证明成功，减少AS疾病活动在数量有限的临床试验。
Tumor necrosis factor inhibitors have demonstrated success in reducing as disease activity in a limited number of clinical trials.
本文综述了包括肿瘤坏死因子抑制剂、白细胞介素1抑制剂、干细胞移植及基因治疗等生物治疗在类风湿性关节炎治疗中的作用。
This article reviews the effect of biotherapy in ra including tumor necrosis factor inhibitor, IL-1inhibitor, stem cell transplantation genetic therapy and so on.
肿瘤坏死因子受体抑制剂，人可溶性，重组。
Tumor Necrosis Factor Receptor Inhibitor, Human Soluble, recombinant.
肿瘤坏死因子受体抑制剂，人可溶性，重组。
Tumor Necrosis Factor Receptor Inhibitor, Human Soluble, recombinant.
应用推荐